DECEMBER - 20225TECH OUTLOOKIntricacies of Precision MedicineIN MY OPINIONAndrew Garrett, PhD, Executive Vice President, Scientific Operations, ICON Clinical Research [NASDAQ: ICLR]08CXO INSIGHTSCell and Gene Therapy ­ Navigating the Next Frontier in BiomanufacturingNarayana Rao, Vice President of Biopharma, Asia Pacific Middle-East Africa, Avantor [NYSE:AVTR]20Medical Affairs Takes Centre StageDr Sarah Tregenza, PhD BSc (Hons), APAC Oncology Medical Affairs Director, Pierre Fabre Group26Revamping Drug Discovery and Development through Technology InnovationDr. Michelle M. Chen, VP and Head of Corporate Development, WuXi Biologics28C O N TE N TSLAST WORDAccelerating Drug Development of Novel Targeted Therapies through Histology-Agnostic Oncology Clinical TrialsHua Gong, SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai Lab30
< Page 4 | Page 6 >